glutathione treatment for parkinson& 39 Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson's Disease: State-of-the-Art MR Spectroscopy and Neuropsychological Study Parkinson's Disease: Bridging Gaps, Building
Description
The rates are broadly similar

Footnotes AgRP Agouti-related peptide AI aromatase inhibitor AMPK AMP-activated protein kinase ARC arcuate nucleus CCK cholecystokinin CEE conjugated equine estrogen CoA coenzyme A E1 estrone E2 17-estradiol ER estrogen receptor ERE estrogen response element EST estrogen sulfotransferase FAS fatty acid synthase GLP-1 glucagon-like peptide-1 GLP-1R GLP-1 receptor GLUT4 glucose transporter 4 GPER G protein-coupled ER HFD high fat diet HGP hepatic glucose production HRT hormone replacement therapy KO knockout LDL low-density lipoprotein leprb leptin receptor LPL lipoprotein lipase LXR liver X receptor MC4 melanocortin 4 MEF2 myocyte enhancer factor 2 MERKO muscle-specific ERKO (mice) NPY neuropeptide Y NTS nucleus tractus solitarius OVX ovariectomy POMC pro-opiomelanocortin PPAR peroxisome proliferator-activated receptor PPT propylpyrazole triol SERM selective estrogen receptor modulator SF1 steroidogenic factor-1 SREBP-1c sterol regulatory element-binding protein 1c STAT3 signal transducer and activator of transcription 3 STZ streptozotocin TSEC tissue-selective estrogen complex VMH ventromedial hypothalamus VMN ventromedial nucleus WAT white adipose tissue

Sartor RB (1997) Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases

CQDs are mainly structured by the core structural component, carbon, which contributes to their abundant surface functional groups and their overall stability [54]

& Laher, I

Brain Behav Immun 19:334344 Goehler LE, Lyte M, Gaykema RP (2007) Infection-induced viscerosensory signals from the gut enhance anxiety: implications for psychoneuroimmunology
